Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIC-FOLFOX vs GemCis in Unresectable Intrahepatic Cholangiocarcinoma
NCT04961970Phase 3Unknown
- Sponsor
- Shiming Biotech
- Start
- Jul 2021
- Primary completion
- Jul 2025
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil, folinic acid in intrahepatic cholangiocarcinoma (ICC), sponsored by Shiming Biotech. Status: unknown.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT04961970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04961970.